QA: Chinook Therapeutics INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001435049_2023_Chinook_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001435049, Chinook Therapeutics INC

  xvar xval
0 AssetsCurrent 385,592,000
1 IntangibleAssetsNetIncludingGoodwill 24,404,000
2 PropertyPlantAndEquipmentNet 16,908,000
3 remainder_Assets 147,180,000
4 LiabilitiesCurrent 50,835,000
5 LiabilitiesNoncurrent 34,494,000
6 remainder_Liabilities 46,814,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 36,463,593
9 ResearchAndDevelopmentExpense 161,722,443
10 remainder_Expenses 19,929,908
11 remainder_Revenues 19,452,732
12 remainder_NetIncome 3,370,073
13 remainder_ComprehensiveNetIncome -1,853,295
  yvar yval
0 Assets 574,084,000
1 Liabilities 132,143,000
2 Expenses 218,115,944
3 Revenues 19,452,732
4 StockholdersEquity 441,941,000
5 NetIncome -195,293,139
6 ComprehensiveNetIncome -196,219,786
7 BaseVar 474,509,522
8 EconomicCapitalRatiobeforeLimitedLiability 2.17
9 EconomicCapitalRatio 3.14

Edgar->Model Mapping

Feature Distribution

Change over Time